US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

Bimatoprost Ophthalmic Solution

Reason Failed Impurities/Degradation Specifications: Out-of-specification result observed in any other individual impurity.

Lupin Pharmaceuticals Inc. D-0635-2020
Class III · Low risk Terminated

Memantine Hydrochloride Extended-release Capsules

Reason Failed Dissolution Specifications: High out of specification result observed at stability studies.

Lupin Pharmaceuticals Inc. NDC 68180-249-09 D-0629-2020
Class III · Low risk Terminated

Moxifloxacin Ophthalmic Solution USP

Reason Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.

AuroMedics Pharma LLC NDC 65862-840-03 D-0789-2020
Class III · Low risk Terminated

VCF Vaginal Contraceptive Foam

Reason Defective Delivery System: canister unit exhibiting propellant leakage or loss, rendering the product and canister unusable

Apothecus Pharmaceutical Corp. NDC 52925-312-14 D-0623-2020
Class III · Low risk Terminated

Timolol Maleate Sterile Opthalmic Solution

Reason Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside was Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml.

Rising Pharmaceuticals, Inc. NDC 64980-513-05 D-1368-2020
Class III · Low risk Terminated

Timolol Maleate USP

Reason Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside was Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml.

Rising Pharmaceuticals, Inc. NDC 64980-514-05 D-1367-2020
Class III · Low risk Terminated

Colostat

Reason Labeling mix-up - Indications on product label are incorrect.

Grato Holdings, Inc. NDC 44911-0411-1 D-1049-2020
Class III · Low risk Terminated

Clobetasol Propionate Foam

Reason Defective delivery system; product is not foaming or is coming out as liquid.

Glenmark Pharmaceuticals Inc., USA NDC 68462-625-27 D-0619-2020
Class III · Low risk Terminated

Clobetasol Propionate Foam

Reason Defective delivery system; product is not foaming or is coming out as liquid.

Glenmark Pharmaceuticals Inc., USA NDC 68462-608-27 D-0618-2020
Class III · Low risk Terminated

Amiodarone Hydrochloride Injection

Reason Crystallization: Presence of visible particulate matter.

AuroMedics Pharma LLC NDC 55150-182-18 D-0522-2020
Class III · Low risk Terminated

Amiodarone Hydrochloride Injection

Reason Crystallization: Presence of visible particulate matter.

AuroMedics Pharma LLC NDC 55150-181-09 D-0521-2020
Class III · Low risk Terminated

Amiodarone Hydrochloride Injection

Reason Crystallization: Presence of visible particulate matter.

AuroMedics Pharma LLC NDC 55150-180-03 D-0520-2020
Class III · Low risk Terminated

Cefdinir for Oral Suspension USP

Reason Presence of Foreign substance: identified as a dead ant.

Lupin Pharmaceuticals Inc. NDC 68180-722-20 D-0306-2020
Class III · Low risk Terminated

Cefdinir for Oral Suspension USP

Reason Presence of Foreign substance: identified as a dead ant.

Lupin Pharmaceuticals Inc. NDC 68180-723-10 D-0305-2020
Class III · Low risk Terminated

Cephalexin for Oral Suspension USP

Reason Presence of Foreign substance: identified as a dead ant.

Lupin Pharmaceuticals Inc. NDC 68180-0441-02 D-0304-2020
Class III · Low risk Terminated

Atorvastatin Calcium Tablets

Reason Presence of Foreign Tablets/Capsules: a single tablet of Pravastatin 40 mg found in bottle of Atorvastatin Calcium 40 mg.

Apotex Inc. NDC 60505-2580-8 D-0153-2020
Class III · Low risk Terminated

PF-Succinylcholine Chloride Injection

Reason Incorrect labeling: Incorrect or missing lot and/or exp date

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center NDC 69374-919-10 D-0154-2020
Class III · Low risk Terminated

Isotretinoin Capsules

Reason Failed Impurities/Degradation Specifications: Tretinoin levels slightly above specification limits.

Amneal Pharmaceuticals, Inc. NDC 69238-1174-3 D-0321-2020